Gajdács M, Urbán E. Relevance of anaerobic bacteremia in adult patients: a never-ending story? Eur J Microbiol Immunol (Bp). 2020;10:64–75.
Cohen-Poradosu R, Kasper DL. Principles and practice of infectious diseases, 9th edn. Churchill Livingstone; 2019. Chapter 242 Anaerobic infections: general concepts.
Nulsen MF, Finlay-Jones JJ, Skinner JM, McDonald PJ. Intra-abdominal abscess formation in mice: quantitative studies on bacteria and abscess-potentiating agents. Br J Exp Pathol. 1983;64:345–53.
CAS PubMed PubMed Central Google Scholar
Stearne LE, Gyssens IC, Goessens WH, Mouton JW, Oyen WJ, van der Meer JW, et al. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a ancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model. Antimicrob Agents Chemother. 2001;45:1394–401.
Article CAS PubMed PubMed Central Google Scholar
Nagaoka K, Yanagihara K, Harada Y, Yamada K, Migiyama Y, Morinaga Y, et al. Establishment of a new murine model of liver abscess induced by Fusobacterium necrophorum injected into the caudal vein. J Med Microbiol. 2013;62:1755–9.
Article CAS PubMed Google Scholar
Chen X, Katchar K, Goldsmith JD, Nanthakumar N, Cheknis A, Gerding DN, et al. A mouse model of Clostridium difficile-associated disease. Gastroenterology. 2008;135:1984–92.
Andersson JA, Peniche AG, Galindo CL, Boonma P, Sha J, Luna RA, et al. New host-directed therapeutics for the treatment of Clostridioides difficile infection. mBio 2020;11:e00053–e00020.
Kumar V, Abbas AK, Aster JC. Robbins & Cotran pathologic basis of disease, 10th edn. Elsevier; 2020. Chapter 3 Inflammation and repair.
Giamarellou H. Anaerobic infection therapy. Int J Antimicrob Agents. 2000;16:341–6.
Article CAS PubMed Google Scholar
Brook I. The role of anaerobic bacteria in bacteremia. Anaerobe. 2010;16:183–9.
Article CAS PubMed Google Scholar
Siewert B, Raptopoulos V, Mueller MF, Rosen MP, Steer M. Impact of CT on diagnosis and management of acute abdomen in patients initially treated without surgery. AJR Am J Roentgenol. 1997;168:173–8.
Article CAS PubMed Google Scholar
Karabulut N, Kiroglu Y, Herek D, Kocak TB, Erdur B. Feasibility of low-dose unenhanced multi-detector CT in patients with suspected acute appendicitis: comparison with sonography. Clin Imaging. 2014;38:296–301.
Neitlich JD, Topazian M, Smith RC, Gupta A, Burrell MI, Rosenfield AT. Detection of choledocholithiasis: comparison of unenhanced helical CT and endoscopic retrograde cholangiopancreatography. Radiology. 1997;203:753–7.
Article CAS PubMed Google Scholar
Vieweg J, Teh C, Freed K, Leder RA, Smith RH, Nelson RH, et al. Unenhanced helical computerized tomography for the evaluation of patients with acute flank pain. J Urol. 1998;160:679–84.
Article CAS PubMed Google Scholar
Arvanitakis M, Delhaye M, De Maertelaere V, Bali M, Winant C, Coppens E, et al. Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis. Gastroenterology. 2004;126:715–23.
Lassmann B, Gustafson DR, Wood CM, Rosenblatt JE. Reemergence of anaerobic bacteremia. Clin Infect Dis. 2007;44:895–900.
Zouggari Y, Lelubre C, Lali SE, Cherifi S. Epidemiology and outcome of anaerobic bacteremia in a tertiary hospital. Eur J Intern Med. 2022;105:63–8.
Vena A, Muñoz P, Alcalá L, Fernandez-Cruz A, Sanchez C, Valerio M, et al. Are incidence and epidemiology of anaerobic bacteremia really changing? Eur J Clin Microbiol Infect Dis. 2015;34:1621–9.
Article CAS PubMed Google Scholar
Wilson JR, Limaye AP. Risk factors for mortality in patients with anaerobic bacteremia. Eur J Clin Microbiol Infect Dis. 2004;23:310–6.
Article CAS PubMed Google Scholar
Kovács K, Nyul A, Lutz Z, Mestyán G, Gajdács M, Urbán E, et al. Incidence and clinical characteristics of anaerobic bacteremia at a university hospital in Hungary: a 5-year retrospective observational study. Antibiotics (Basel). 2022;11:1326.
Nagaoka K, Iwanaga N, Takegoshi Y, Murai Y, Kawasuji H, Miura M, et al. Mortality risk factors and fulminant subphenotype in anaerobic bacteremia: a 10-year retrospective, multicenter, observational cohort study. Eur J Clin Microbiol Infect Dis. 2024;43:459–67.
Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676–82.
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–10.
Article CAS PubMed PubMed Central Google Scholar
Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286:1754–8.
Article CAS PubMed Google Scholar
Speirs G, Warren RE, Rampling A. Clostridium tertium septicemia in patients with neutropenia. J Infect Dis. 1988;158:1336–40.
Article CAS PubMed Google Scholar
Liu F, Xue S, Zhang Y, Yang J, Hu J, Li D, et al. Clostridium perfringens sepsis in three patients with acute leukemia and review of the literature. Int J Hematol. 2021;113:508–17.
Article PubMed PubMed Central Google Scholar
Fanourgiakis P, Vekemans M, Georgala A, Daneau D, Vandermies A, Grenier P, et al. Febrile neutropenia and Fusobacterium bacteremia: clinical experience with 13 cases. Support Care Cancer. 2003;11:332–5.
Article CAS PubMed Google Scholar
Morris AJ, Wilson ML, Mirrett S, Reller LB. Rationale for selective use of anaerobic blood cultures. J Clin Microbiol. 1993;31:2110–3.
Article CAS PubMed PubMed Central Google Scholar
Lichtenstern C, Brenner T, Bardenheuer HJ, Weigand MA. Predictors of survival in sepsis: what is the best inflammatory marker to measure? Curr Opin Infect Dis. 2012;25:328–36.
Article CAS PubMed Google Scholar
Suzaki A, Hayakawa S. Clinical and microbiological features of fulminant haemolysis caused by Clostridium perfringens bacteraemia: unknown pathogenesis. Microorganisms. 2023;11:824.
Comments (0)